BioCentury | Apr 3, 2021
Management Tracks

Biotech CEOs in China: a broadening talent pool

...Dimensions Capital to become CEO of Gracell Biotechnologies Inc. (NASDAQ:GRCL), made his CEO debut at Cellular Biomedicine Group Inc....
BioCentury | Jan 9, 2021
Finance

Gracell looks to NASDAQ IPO to place it among CAR T leaders

...Chairman and CEO William Wei Cao, who co-founded and was CEO of cell therapy company Cellular Biomedicine Group Inc....
BioCentury | Dec 21, 2020
Finance

Dec. 21-23 Financial Quick Takes: Venture rounds for SomaLogic, ONL; plus Jacobio’s HK listing, Cullinan, Gracell and Zhaoke file for IPOs, and more

...candidate CLN-081, an EGFR inhibitor. Gracell's CEO is William Cao, who was the co-founding CEO of Cellular Biomedicine Group Inc....
BioCentury | Dec 10, 2020
Management Tracks

Ricks takes baton from Caforio at PhRMA; plus Bluestone joins Gilead board and Derrick Li returns to investment banking, joining Baird

...its global healthcare investment banking team. He was head of strategy and investor relations at Cellular Biomedicine Group Inc....
...CSO at Akorn Inc. (NASDAQ:AKRX). Danielle Golovin Gilead Sciences Inc. Robert W. Baird Phagelux Inc. Chiesi Farmaceutici S.p.A. Oyster Point Pharma Inc. Cellular Biomedicine Group Inc. Pfizer...
BioCentury | Aug 15, 2020
Finance

As CBMG moves to complete go-private deal, pressure on U.S.-listed Chinese companies mounts in Washington

...Chinese companies face in considering where to list and whether to remain listed in the U.S. Cellular Biomedicine Group Inc....
...over the company’s closing price of $17.67 on Nov. 8, 2019, before the initial proposal. Virginia Li Cellular Biomedicine Group Inc. PCAOB chs2020...
BioCentury | Nov 14, 2019
Company News

Nov. 13 Company Quick Takes: FDA panel rebuffs Jardiance; plus Nucala, Cellular Biomedicine, BeiGene, Autolus and Noile-Immune

...is approved for severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis. Cellular Biomedicine considering take-private proposal Cellular Biomedicine Group Inc....
...19; IL-7 - Interleukin-7; SGLT2 - Sodium-glucose cotransporter 2 BioCentury Staff tislelizumab (BGB-A317) Jardiance, empagliflozin (BI-10773) Noile-Immune Biotech Inc. BeiGene Ltd. Cellular Biomedicine Group Inc. Boehringer...
BioCentury | Jul 13, 2019
Finance

How crossover, insider support and big money correlated with performance across 1H19 IPOs

...Euronext:GNFT; NASDAQ:GNFT) 3/27/19 $145.2 $778.9 $757.0 -3% MyoKardia Inc. (NASDAQ:MYOK) 3/26/19 $288.9 $2,345.2 $2,310.0 -2% Cellular Biomedicine Group Inc....
BioCentury | Jun 14, 2019
Company News

Tessa forms JV with biohub to bring its cell therapies to China

...brought its CAR T cell therapy Kymriah tisagenlecleucel to China in a manufacturing deal with Cellular Biomedicine Group Inc....
...Li, Staff Writer Kymriah, tisagenlecleucel (CTL019, cart-19, tisagenlecleucel-t) Thalomid, thalidomide (Actimid, CDC 394, Synovir, Thalidomide Celgene, Thalidomide Pharmion) Cellular Biomedicine Group Inc. Gilead...
BioCentury | Feb 28, 2019
Financial News

Gracell raises $85M series B to advance cell therapies

...tumors. Founder, Chairman and CEO Wei (William) Cao is a veteran of cell therapy company Cellular Biomedicine Group Inc....
BioCentury | Feb 25, 2019
Financial News

Gracell raises $85M series B to advance cell therapies

...tumors. Founder, Chairman and CEO Wei (William) Cao is a veteran of cell therapy company Cellular Biomedicine Group Inc....
Items per page:
1 - 10 of 59
BioCentury | Apr 3, 2021
Management Tracks

Biotech CEOs in China: a broadening talent pool

...Dimensions Capital to become CEO of Gracell Biotechnologies Inc. (NASDAQ:GRCL), made his CEO debut at Cellular Biomedicine Group Inc....
BioCentury | Jan 9, 2021
Finance

Gracell looks to NASDAQ IPO to place it among CAR T leaders

...Chairman and CEO William Wei Cao, who co-founded and was CEO of cell therapy company Cellular Biomedicine Group Inc....
BioCentury | Dec 21, 2020
Finance

Dec. 21-23 Financial Quick Takes: Venture rounds for SomaLogic, ONL; plus Jacobio’s HK listing, Cullinan, Gracell and Zhaoke file for IPOs, and more

...candidate CLN-081, an EGFR inhibitor. Gracell's CEO is William Cao, who was the co-founding CEO of Cellular Biomedicine Group Inc....
BioCentury | Dec 10, 2020
Management Tracks

Ricks takes baton from Caforio at PhRMA; plus Bluestone joins Gilead board and Derrick Li returns to investment banking, joining Baird

...its global healthcare investment banking team. He was head of strategy and investor relations at Cellular Biomedicine Group Inc....
...CSO at Akorn Inc. (NASDAQ:AKRX). Danielle Golovin Gilead Sciences Inc. Robert W. Baird Phagelux Inc. Chiesi Farmaceutici S.p.A. Oyster Point Pharma Inc. Cellular Biomedicine Group Inc. Pfizer...
BioCentury | Aug 15, 2020
Finance

As CBMG moves to complete go-private deal, pressure on U.S.-listed Chinese companies mounts in Washington

...Chinese companies face in considering where to list and whether to remain listed in the U.S. Cellular Biomedicine Group Inc....
...over the company’s closing price of $17.67 on Nov. 8, 2019, before the initial proposal. Virginia Li Cellular Biomedicine Group Inc. PCAOB chs2020...
BioCentury | Nov 14, 2019
Company News

Nov. 13 Company Quick Takes: FDA panel rebuffs Jardiance; plus Nucala, Cellular Biomedicine, BeiGene, Autolus and Noile-Immune

...is approved for severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis. Cellular Biomedicine considering take-private proposal Cellular Biomedicine Group Inc....
...19; IL-7 - Interleukin-7; SGLT2 - Sodium-glucose cotransporter 2 BioCentury Staff tislelizumab (BGB-A317) Jardiance, empagliflozin (BI-10773) Noile-Immune Biotech Inc. BeiGene Ltd. Cellular Biomedicine Group Inc. Boehringer...
BioCentury | Jul 13, 2019
Finance

How crossover, insider support and big money correlated with performance across 1H19 IPOs

...Euronext:GNFT; NASDAQ:GNFT) 3/27/19 $145.2 $778.9 $757.0 -3% MyoKardia Inc. (NASDAQ:MYOK) 3/26/19 $288.9 $2,345.2 $2,310.0 -2% Cellular Biomedicine Group Inc....
BioCentury | Jun 14, 2019
Company News

Tessa forms JV with biohub to bring its cell therapies to China

...brought its CAR T cell therapy Kymriah tisagenlecleucel to China in a manufacturing deal with Cellular Biomedicine Group Inc....
...Li, Staff Writer Kymriah, tisagenlecleucel (CTL019, cart-19, tisagenlecleucel-t) Thalomid, thalidomide (Actimid, CDC 394, Synovir, Thalidomide Celgene, Thalidomide Pharmion) Cellular Biomedicine Group Inc. Gilead...
BioCentury | Feb 28, 2019
Financial News

Gracell raises $85M series B to advance cell therapies

...tumors. Founder, Chairman and CEO Wei (William) Cao is a veteran of cell therapy company Cellular Biomedicine Group Inc....
BioCentury | Feb 25, 2019
Financial News

Gracell raises $85M series B to advance cell therapies

...tumors. Founder, Chairman and CEO Wei (William) Cao is a veteran of cell therapy company Cellular Biomedicine Group Inc....
Items per page:
1 - 10 of 59